Interventional Neurology Devices And Equipment Global Market Report 2024

The interventional neurology devices and equipment market size has grown strongly in recent years. It will grow from $2.19 billion in 2023 to $2.38 billion in 2024 at a compound annual growth rate (CAGR) of 8.7%. The growth observed during the historic period can be attributed to several key factors, including the rising incidence of neurological disorders, the aging population, increased awareness and diagnosis of strokes, and the adoption of a multidisciplinary approach to neurovascular healthcare.

The interventional neurology devices and equipment market size is expected to see strong growth in the next few years. It will grow to $3.28 billion in 2028 at a compound annual growth rate (CAGR) of 8.3%. The expected growth in the forecast period can be attributed to various factors, including the increasing adoption of minimally invasive procedures, the growth of emerging markets, regulatory support and reimbursement initiatives, and the utilization of telehealth and remote consultations. Notable trends anticipated during the forecast period encompass the integration of artificial intelligence (AI) and image analysis, the use of robotics and navigation technologies, the development of patient-specific devices, and the establishment of hybrid operating rooms.

The Interventional neurology devices market is experiencing growth driven by the increasing number of patients with neurological disorders. Neurological disorders, such as Alzheimer's disease, cerebrovascular diseases including stroke, migraines, and other headache disorders, are on the rise. Several factors contribute to the surge in neurological disorders, including the rapid increase in the geriatric population, elevated stress levels among young individuals, and head injuries resulting from accidents. For instance, the Brain Aneurysm Foundation estimates that approximately 6 million people in the United States suffer from unruptured brain aneurysms. Additionally, according to the World Health Organization, over 50 million individuals have epilepsy, and more than 47 million are affected by dementia. Consequently, the substantial increase in the incidence of neurological disorders is poised to drive market growth during the forecast period.

The primary categories of interventional neurology devices and equipment include aneurysm coiling and embolization devices, cerebrospinal fluid management devices, neuro thrombectomy devices, and various support devices. Neuro thrombectomy devices are utilized for the mechanical removal of thrombi from intracranial arteries via angiographic procedures. Aneurysm coiling and embolization devices consist of embolic coils, flow diversion devices, and liquid embolic devices. The angioplasty device category includes carotid artery stents and embolic protection systems. Support devices encompass micro guidewires and microcatheters, while neurothrombectomy devices are further divided into clot retrieval devices, suction and aspiration devices, and snares. These devices find application in a range of healthcare settings, including hospitals, neurology clinics, ambulatory care centers, and others.

The interventional neurology devices and equipment market research report is one of a series of new reports that provides interventional neurology devices and equipment market statistics, including interventional neurology devices and equipment industry global market size, regional shares, competitors with a interventional neurology devices and equipment market share, detailed interventional neurology devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the interventional neurology devices and equipment industry. This interventional neurology devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The demand for minimally invasive treatments is expected to be a key driver of the interventional neurology devices and equipment market in the future. Minimally invasive treatments involve medical interventions designed to achieve therapeutic or diagnostic outcomes with minimal disruption to the body's tissues and structures. In the treatment of neurological disorders, minimally invasive procedures are gaining popularity, utilizing interventional neurology devices to offer safer, more effective, and less disruptive options for patients. For example, in January 2023, reports from Intuitive Surgical Inc., a US-based manufacturer of robotic products, indicated that there were approximately 1,875,000 surgical procedures performed using the Vinci Surgical System. This marked a significant 18% increase compared to the approximately 1,594,000 procedures conducted with Vinci Surgical Systems in 2021. Therefore, the growing demand for minimally invasive treatments is a driving force behind the expansion of the interventional neurology devices and equipment market.

The growth of the interventional neurological devices market is being hampered by strict regulatory policies imposed by the US FDA for device approval. FDA regulations classify most interventional neurological devices as class 3 devices, requiring extensive approvals from regulatory bodies, resulting in a time-consuming approval process. For instance, obtaining approval for class 3 devices may take more than 36 months, increasing the overall cost of product development and negatively impacting the market.

The latest technological development by Stryker Inc., the Neuroform Atlas Stent System, is anticipated to deliver significant results in the treatment of brain aneurysms with embolic coils. The introduction of such technologies is expected to drive the interventional neurological device market in the future. The Atlas stent system offers robust support during coiling procedures, designed to provide the necessary coil support and wall apposition for effective stent-assisted coiling. Neuroform Atlas features enhanced stent conformability, a low-profile delivery system, and high deployment accuracy even in distal anatomy, making it the preferred choice among neurosurgeons and steering the market.

Prominent companies operating in the interventional neurology devices and equipment market are actively developing innovative products like SenTiva DUO to offer a new treatment option for patients with drug-resistant epilepsy who were previously ineligible for the latest VNS therapy. SenTiva DUO is an implantable pulse generator (IPG) with a dual-pin header designed to provide vagus nerve stimulation (VNS) therapy for drug-resistant epilepsy treatment. For instance, in February 2023, LivaNova Plc., a UK-based medical device company, introduced SenTiva DUO, offering a new treatment option for patients with drug-resistant epilepsy who were previously unable to receive the latest VNS therapy. It presents several advantages over the original SenTiva, including a smaller size, longer battery life, and compatibility with dual-pin leads.

Major companies operating in the interventional neurology devices and equipment market include Medtronic PLC, Stryker Corporation, Terumo Corporation, Penumbra Inc., COVIDien, Abbott Laboratories, Merit Medical Systems Inc., W. L. Gore & Associates, Bayer AG, MicroPort Scientific Corporation, Boston Scientific Corporation, Johnson & Johnson, Medikit Co. Ltd., Acandis GmbH, Biosensors International Ltd., Integra LifeSciences Holdings Corporation, Magstim C-Ltd., UreSil LLC, Cook Group Incorporated, Siemens Healthineers, B. Braun Melsungen AG, Integer Holdings Corporation, Nihon Kohden Corporation, LivaNova, Teleflex Incorporated, Balt Extrusion SAS, Rapid Medical Ltd., phenox GmbH, Spiegelberg GmbH & Co. KG

North America was the largest region in the global interventional neurology devices and equipment market in 2023. Asia-Pacific was the second-largest region in the interventional neurology devices and equipment market. The regions covered in the interventional neurology devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the interventional neurology devices and equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The interventional neurology devices and equipment market consists of sales of instruments such as carotid artery stents, embolic protection systems, micro guide wires, and micro catheters. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.